Paul Adepoju Authors

Paul Adepoju pauladepoju

Paul Adepoju is a Nigeria-based Devex Contributing Reporter, academic, and author. He covers health and tech in Africa for leading local and international media outlets including CNN, Quartz, and The Guardian. He's also the founder of healthnews.africa. He is completing a doctorate in cell biology and genetics and holds several reporting awards in health and tech.

Latest Articles

Malaria
Malaria
'Malaria thrives on chaos' — and the US aid freeze is creating it
14 Feb 2025
Despite waivers for lifesaving programs, the U.S. aid freeze continues to disrupt malaria prevention efforts. The uncertainty and delays threaten to reverse progress, putting millions at risk.
Global health
Global health
Fatigue and fog: Navigating Nigeria’s long COVID crisis
16 Jan 2025
The COVID-19 pandemic may have subsided, but the battle is far from over for millions. In the shadows of recovery lies a new epidemic: long COVID, a silent storm reshaping lives, economies, and health care systems worldwide.
Global health
Global health
Can saving lives be profitable? These African health startups think so
3 Dec 2024
Sustainable innovation is crucial for strengthening health systems, particularly in low- and middle-income countries in Africa. But investors have historically been hesitant to engage with Africa's health care sector.
Global Health
Global Health
Can personalized medicine alter South Africa's fight against HIV?
31 Oct 2024
South Africa's HIV Host Genome Project seeks to unlock the genetic factors that enable a rare group of HIV-positive individuals, known as "elite controllers," to naturally suppress the virus without needing antiretroviral medication.
Global health
Global health
How a new vaccine candidate could outpace Lassa fever's deadly grip
1 Aug 2024
The inaugural Phase 2 Lassa fever vaccine clinical trial, supported by CEPI and IAVI, commenced in Nigeria and Liberia.
Global Health
Global Health
A new injectable could prevent malaria. What's standing in its way?
11 Jul 2024
Though health experts agree that monoclonal antibodies could be the next big thing in malaria prevention, several significant challenges stand in the way of their widespread deployment.
Global health
Global health
Is brain drain limiting Africa’s genomics potential?
11 Apr 2024
A wide human capacity gap threatens Africa's genomics goals but efforts to train more scientists are being hindered by brain drain as trained scientists migrate abroad in search of better opportunities.
Global health
Global health
Gates Foundation commits $200M to develop affordable childhood vaccines
3 May 2023
The Bill & Melinda Gates Foundation announced a new $200 million commitment to be awarded over the next 18 months to support the development and delivery of vaccines to prevent pneumonia, meningitis, and neonatal sepsis.
Global health
Global health
WHO targets unvaccinated children as top priority for polio eradication
4 Apr 2023
Following detections of vaccine-derived poliovirus in Burundi and the Democratic Republic of Congo the World Health Organization and its partners are planning vaccination campaigns to reach children who are unvaccinated or under-vaccinated.
Global health
Global health
Neighbors on alert as Equatorial Guinea and Tanzania battle Marburg
29 Mar 2023
As regional health authorities work with governments in Equatorial Guinea and Tanzania to scale up control measures to end their Marburg virus outbreaks, neighboring countries are now on high alert and are sensitizing citizens on the disease.
See all articles by Paul Adepoju

Paul Adepojupauladepoju

Latest Articles

Paul Adepoju pauladepoju